Coral Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Coral Laboratories	Brooks Laboratories	Kimia Biosciences
Operational Metrics
Financials
5 yr Average ROE	8.16 %	-21.13 %	-335.15 %
5yr average Equity Multiplier	1.18	1.68	66.02
5yr Average Asset Turnover Ratio	0.47	0.62	1.14
5yr Avg Net Profit Margin	14.82 %	-21.45 %	-0.67 %
Price to Book	0.78	1.53	12.26
P/E	9.57	15.37	14.78
5yr Avg Cash Conversion Cycle	35.5 Days	23.75 Days	-33.97 Days
Inventory Days	69.25 Days	83.11 Days	101.63 Days
Days Receivable	98.13 Days	80.26 Days	98.68 Days
Days Payable	131.4 Days	163.46 Days	171.28 Days
5yr Average Interest Coverage Ratio	171.88	-11.18	0.78
5yr Avg ROCE	10.48 %	-11.18 %	10.6 %
5yr Avg Operating Profit Margin	14.88 %	-10.26 %	3.89 %
5 yr average Debt to Equity	0.02	0.18	29.85
5yr CAGR Net Profit	12.26 %	-12.45 %	13.51 %
5yr Average Return on Assets	6.95 %	-13.31 %	-0.69 %
Shareholdings
Promoter Holding	71.51 %	52.62 %	74.94 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-13.79 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	9.9 %	0.0

	Coral Laboratories	Brooks Laboratories	Kimia Biosciences
Product Wise Break-Up	Product Wise Break-Up Formulations 100.0 Pharmaceuticals 0	Product Wise Break-Up Formulations 0 Pharmaceutical 100.0	Product Wise Break-Up Formulations 0 Pharmaceutical 100.0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 57.87 Ethiopia 21.5 India 19.05 International 0 Domestic 0 Others 1.58	-	Location Wise Break-Up Rest of the World 0 India 0 Ethiopia 0 International 18.28 Domestic 81.72